We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Spire Healthcare Group plc (SPI) Ordinary 1p

Sell:247.50p Buy:249.00p 0 Change: 9.50p (3.98%)
FTSE 250:0.57%
Market closed |  Prices as at close on 18 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:247.50p
Buy:249.00p
Change: 9.50p (3.98%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 18 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:247.50p
Buy:249.00p
Change: 9.50p (3.98%)
Market closed |  Prices as at close on 18 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Spire Healthcare Group plc is a United Kingdom-based company that owns and operates private hospitals and clinics in the United Kingdom (UK) and provides a range of private healthcare services. The Company offers a range of treatments and services, such as allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, dental surgery, eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart treatments, neurosurgery and neurology, hip and knee, kidney treatments, physiotherapy, podiatry, respiratory medicine, scans and investigations, skin treatments, spinal surgery and treatments, sports science, vascular surgery, weight loss, women's health, and others. Its tests and scans include cardiac computerized tomography (CT), CT scans, magnetic resonance imaging (MRI) scans, ultrasound scans, and x-rays.

Contact details

Address:
3 Dorset Rise
LONDON
EC4Y 8EN
United Kingdom
Telephone:
+ (0)
Website:
https://www.spirehealthcare.com/

Important dates

Future events
Final dividend payment date 21 June 2024 21/06/24
Final ex-dividend date 23 May 2024 23/05/24
AGM 09 May 2024 09/05/24
Past events
Final results 29 February 2024 29/02/24
Interim results 14 September 2023 14/09/23
Final dividend payment date 23 June 2023 23/06/23
Final ex-dividend date 25 May 2023 25/05/23
AGM 11 May 2023 11/05/23

General stock information

EPIC:
SPI
ISIN:
GB00BNLPYF73
Market cap:
£1.00 billion
Shares in issue:
403.82 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 250,FTSE 350,FTSE All Share

Key personnel

  • Justinian Ash
    Chief Executive Officer, Executive Director
  • Jitesh Sodha
    Chief Financial Officer, Executive Director
  • Harbant Samra
    Deputy Chief Financial Officer
  • John Forrest
    Chief Operating Officer
  • Mantraraj Budhdev
    Group General Counsel
  • Cathy Cale
    Group Medical Director
  • Peter Corfield
    Chief Commercial Officer
  • Lisa Grant
    Group Clinical Director, Chief Nurse
  • Rachel King
    Group People Director
  • Philip Davies
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.